Table 4. Dynamic changes in liver function indicators in patients with liver injury.
Firstly abnormal liver function indicator (n=190) | Peak liver function indicator (n=173) | Pre-discharge liver function indicator (n=179)* | |
Course of a disease (day) | 8 (4–13) | 11 (8–16) | 19 (15–25.5) |
ALT | |||
Abnormal number (%) | 108, 56.8% | 129, 74.6% | 80, 44.7% |
Median (quartile) (U/L) | 55 (47–72.8) | 72 (55.5–99.5) | 58 (48–70.8) |
Max | 310 | 426 | 224 |
AST | |||
Abnormal number (%) | 83, 43.7% | 86, 49.7% | 21, 11.7% |
Median (quartile) (U/L) | 52 (45–71) | 59 (49–82) | 49 (42–61.5) |
Max | 488 | 266 | 122 |
ALP | |||
Abnormal number (%) | 7, 3.7% | 8, 4.6% | 1, 0.56% |
Median (quartile) (U/L) | 144 (127–220) | 130.5 (127.5–199.5) | / |
Max | 430 | 650 | 138 |
γ-GT | |||
Abnormal number (%) | 60, 31.6% | 77, 44.5% | 47, 26.3% |
Median (quartile) (U/L) | 96 (75–131.3) | 105 (78.5–128) | 86 (73–104) |
Max | 402 | 1135 | 204 |
TB | |||
Abnormal number (%) | 58, 30.5% | 55, 31.8% | 168.9%) |
Median (quartile) (μmol/L) | 22.2 (19.9–27.0) | 26.1 (21.4–31.6) | 21.2 (19.7–29.5) |
Max | 91.1 | 91.1 | 45.6 |
* n=179, excluding 8 cases which had not discharged and 3 deaths as of 13 March 2020.